Citigroup’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22 | Buy |
+19
| New | +$22 | ﹤0.01% | 4816 |
|
|
2022
Q2 | – | Sell |
-7,312
| Closed | -$59K | – | 5410 |
|
|
2022
Q1 | $59K | Buy |
+7,312
| New | +$59K | ﹤0.01% | 3954 |
|
|
2021
Q2 | – | Sell |
-437
| Closed | -$10K | – | 5438 |
|
|
2021
Q1 | $10K | Sell |
437
-741
| -63% | -$17K | ﹤0.01% | 4961 |
|
|
2020
Q4 | $35K | Buy |
1,178
+860
| +270% | +$25.6K | ﹤0.01% | 4306 |
|
|
2020
Q3 | $5K | Sell |
318
-421
| -57% | -$6.62K | ﹤0.01% | 4629 |
|
|
2020
Q2 | $18K | Sell |
739
-628
| -46% | -$15.3K | ﹤0.01% | 4316 |
|
|
2020
Q1 | $28K | Buy |
1,367
+356
| +35% | +$7.29K | ﹤0.01% | 4170 |
|
|
2019
Q4 | $31K | Buy |
1,011
+322
| +47% | +$9.87K | ﹤0.01% | 4275 |
|
|
2019
Q3 | $23K | Sell |
689
-712
| -51% | -$23.8K | ﹤0.01% | 4199 |
|
|
2019
Q2 | $45K | Buy |
1,401
+60
| +4% | +$1.93K | ﹤0.01% | 4164 |
|
|
2019
Q1 | $38K | Buy |
1,341
+119
| +10% | +$3.37K | ﹤0.01% | 4191 |
|
|
2018
Q4 | $50K | Sell |
1,222
-148
| -11% | -$6.06K | ﹤0.01% | 3914 |
|
|
2018
Q3 | $64K | Buy |
+1,370
| New | +$64K | ﹤0.01% | 3897 |
|
|
2015
Q4 | – | Sell |
-1,150
| Closed | -$12K | – | 5411 |
|
|
2015
Q3 | $12K | Hold |
1,150
| – | – | ﹤0.01% | 4297 |
|
|
2015
Q2 | $21K | Hold |
1,150
| – | – | ﹤0.01% | 4230 |
|
|
2015
Q1 | $17K | Hold |
1,150
| – | – | ﹤0.01% | 4482 |
|
|
2014
Q4 | $15K | Hold |
1,150
| – | – | ﹤0.01% | 4707 |
|
|
2014
Q3 | $21K | Buy |
+1,150
| New | +$21K | ﹤0.01% | 4239 |
|
|
2014
Q2 | – | Sell |
-1,150
| Closed | -$21K | – | 5473 |
|
|
2014
Q1 | $21K | Hold |
1,150
| – | – | ﹤0.01% | 4453 |
|
|
2013
Q4 | $20K | Hold |
1,150
| – | – | ﹤0.01% | 4587 |
|
|
2013
Q3 | $20K | Sell |
1,150
-1
| -0.1% | -$17 | ﹤0.01% | 4278 |
|
|
2013
Q2 | $23K | Buy |
+1,151
| New | +$23K | ﹤0.01% | 4134 |
|